Founded Year



Series E | Alive

Total Raised


Last Raised

$50M | 2 yrs ago

About Genalyte

Genalyte transforms the doctor-patient relationship by providing rapid diagnostic testing right in the doctor's office. The company's technology delivers results to physicians in minutes from just a single drop of blood, yielding better outcomes for the patient, empowering doctors to be more effective, and creating a more efficient healthcare system.

Genalyte Headquarter Location

10520 Wateridge Circle

San Diego, California, 92121,

United States


ESPs containing Genalyte

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Medical Devices Tech

Point-of-care (POC) testing refers to diagnostic lab tests that can be performed rapidly, reliably, and easily at or near the point of care. Starting with a biological sample, POC tests detect or quantify certain analytes — such as infectious agents, cardiac markers, and blood glucose — to inform clinical decision making.

Genalyte named as Outperformer among 15 other companies, including BD, Accellix, and Coyote Bioscience.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Genalyte's Products & Differentiation

See Genalyte's products and how their products differentiate from alternatives and competitors

  • Merlin

    A freestanding automated lab that runs a comprehensive set of tests onsite with remote central lab oversight via the Cloud for health systems, physician clinics and retail health clinics. The size of a standard refrigerator, Merlin is a self-contained, temperature controlled lab. Patient samples are run onsite with results in less than 30 minutes.


    No competitor in the market can deliver the breadth of tests that Genalyte can perform in < 30 minutes. The market leaders (LabCorps/Quest) have maintained their existing centralized, multi-day mod… 

Research containing Genalyte

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Genalyte in 1 CB Insights research brief, most recently on Mar 21, 2022.

Expert Collections containing Genalyte

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Genalyte is included in 5 Expert Collections, including Digital Health.


Digital Health

122 items

Startups recreating how healthcare is delivered


Medical Devices

11,772 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Health Monitoring & Diagnostics

3,095 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Health IT

7,900 items

Genalyte Patents

Genalyte has filed 9 patents.

The 3 most popular patent topics include:

  • Sensors
  • Inflammations
  • Laser science
patents chart

Application Date

Grant Date


Related Topics




Optical devices, Microscopy, Sensors, Spectroscopy, Laser science


Application Date


Grant Date



Related Topics

Optical devices, Microscopy, Sensors, Spectroscopy, Laser science



Latest Genalyte News

Global Lab-on-a-Chip Market (2021 to 2027) - Featuring Abbott Laboratories, Danaher and Genalyte Among Others -

Jan 31, 2022

Zepto Life Technology, LLC The market is set to display impressive growth during the forecast period with some key trends emerging, such as the growing focus on the number of LoC applications in the medical field and the rising incidence related to chronic diseases. The global lab-on-a-chip market impacted positively during the COVID-19 pandemic despite most of the economic activities were halted during Q1 and Q2 2020. The activities associated with the manufacturing of products related to lab-on-a-chip had increased owing to the COVID-19 antibody test. The global lab-on-a-chip market is segmented based on product type, application, technology, and end-user. Based on the product type segment, the market is segmented into reagents and consumables, and instruments. Among these, the instruments and reagents and consumables segments are anticipated to experience rapid growth. Based on the application segment, the market is segmented into genomics, proteomics, diagnostics, and drug discovery. Based on the technology segment, the market is segmented into DNA microarrays and microfluidic chips. Further, based on the end-user segment, the market is bifurcated into hospitals and diagnostic labs, pharmaceutical companies, and individuals. Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is expected to have the fastest-growing region in the market. Increasing technological development along with investments in scientific research which were once a stronghold of the US and a few European economies such as France, Italy, and Germany, is set to expand to emerging economies, to be planned predominantly in the Asia-Pacific region. The growing number of people getting affected by infectious disease in the Asian economies of Japan, South Korea, Taiwan, and China, is set to increase the demand for lab-on-a-chip in diagnosis. Market Segmentation Global Lab-On-A-Chip Market Research And Analysis By Application Global Lab-On-A-Chip Market Research And Analysis By Technology Global Lab-On-A-Chip Market Research And Analysis By End-User The Report Covers This report also includes a detailed and extensive market overview with key analyst insights. An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. Analysis of regional regulations and other government policies impacting the global lab-on-a-chip market. Insights about market determinants that are global lab-on-a-chip market. Detailed and extensive market segments with the regional distribution of forecasted revenues. Extensive profiles and recent developments of market players. Key Topics Covered:

Genalyte Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Genalyte Rank

  • When was Genalyte founded?

    Genalyte was founded in 2007.

  • Where is Genalyte's headquarters?

    Genalyte's headquarters is located at 10520 Wateridge Circle, San Diego.

  • What is Genalyte's latest funding round?

    Genalyte's latest funding round is Series E.

  • How much did Genalyte raise?

    Genalyte raised a total of $141.8M.

  • Who are the investors of Genalyte?

    Investors of Genalyte include Redmile Group, Khosla Ventures, Provenio Capital, HBM Partners, Samsara BioCapital and 5 more.

  • Who are Genalyte's competitors?

    Competitors of Genalyte include Visby Medical, Cardea Bio, Baebies, MeMed, Accellix, Inflammatix, Oxford Nanopore Technologies, LumiraDx, Cue Health, Roche Holding and 26 more.

  • What products does Genalyte offer?

    Genalyte's products include Merlin.

You May Also Like

Cepheid Logo

Cepheid is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial, and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification, and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. Cepheid previously traded under the ticker NASDAQ: CPHD.

Baebies Logo

Baebies developed a nimble bioassay automation platform to rapidly perform multiplex enzymatic assays and other tests. The company licensed its core technology, digital microfluidics, from Illumina. In addition to a technology license in newborn screening that does not include sequencing, Baebies also received equipment, contracts, and other consideration in exchange for a share of ownership in the new company. The company was founded in 2013 and is based in Durham, North Carolina.

Sight Diagnostics

Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.

Hemex Health Logo
Hemex Health

Hemex creates affordable, life-changing medical diagnostics for under-served people everywhere. Its diagnostic platform is designed to reach populations at risk for malaria and sickle cell disease.

Truvian Sciences Logo
Truvian Sciences

Truvian Sciences is a healthcare company at the intersection of diagnostics and consumer technology. Its automated benchtop system produces lab-accurate results for a full suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian's system delivers an alternative to off-site labs, providing immediate insights to inform healthcare decisions.

BD Logo

BD is a medical technology company that manufactures and sells a broad range of supplies, devices, and systems for use by healthcare professionals, medical research institutions, industry, and the general public.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.